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Letters to the Editor572investigators, access to echocardiography was poor in nearly all
countries; only 16% could obtain echocardiograms directly and 34%
via specialists within 1 month (4).
As underscored by Abhayaratna (2), given the growing challenge
to maximize health gains with limited healthcare resources, studies
should be designed with a view to addressing the key question of “at
what cost” should echocardiography be used as a screening tool.
There is an ongoing discussion on what is the most cost-effective
strategy to screen for left ventricular systolic dysfunction (5). Data
from literature and our own experience seem to be strong enough to
consider point-of-care, hand-carried echocardiography as a reliable
HF screening method. We recently demonstrated that simplified
echocardiographic examinations, using a simplified imaging proto-
col, performed by a noncardiologist with basic training in echocar-
diography, yielded significant diagnostic and prognostic informa-
tion in a community (in a cohort of patients with HF and/or HF
risk factors) (6). In the multivariate analysis, both abnormal
point-of-care echocardiogram and elevated NT-proBNP levels
were independent predictors of the adverse outcome. Of interest,
the best cutoff value for NT-proBNP to predict combined endpoint
was 206 pg/ml, which is similar to that obtained by Kalogeropoulos
et al. (190 pg/ml) (1).
One of the tasks of primary care physicians is to “prevent sickness
from clinically manifest HF,” by the early detection of HF risk
factors and asymptomatic left ventricular dysfunction. Point-of-care
hand-carried ultrasound examinations performed by primary care
physicians, using simplified imaging protocols would render them
“superior doctors” and limit the referrals to standard echocardiog-
raphy to those patients in whom “ultrasound stethoscope” screening
was positive or equivocal. Although careful and methodical studies
looking at the reliability, accuracy, and cost-effectiveness of diag-
noses made by caregivers with basic training have yet to be done,
they are important as we are facing a HF epidemic and a wide
application of ultrasound stethoscopes might change the standards
of care and make them more cost-effective.
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We thank Dr. Lipczyn´ska and colleagues for their interest in our work
(1). However, it is crucial to differentiate between the various uses of
chocardiography in heart failure (HF). Our paper focuses on risk
tratification for future clinical (stage C) HF and has implications for
ubclinical heart disease (stage B HF) screening (1). Therefore, our
nferences cannot be extrapolated to clinical HF, where assessment by
chocardiography is a class I indication by most guidelines. The low
ates of echocardiography referral for patients with suspected or con-
rmed HF among primary care physicians (PCPs) cannot be solely
ttributed to cost or limited access as implied. Delayed uptake of
vidence-based practices among PCPs is a key factor. In IMPROVE-
ENT (Improvement programme in evaluation and management of
eart failure) (2), 82% of patients eventually had echocardiography
espite 45% of PCPs recommending it, a discrepancy that is difficult to
xplain by waiting times or workforce distribution by that time (3). In
HAPE (Study Group on HF Awareness and Perception in Europe),
he disparities in HF management between internists, PCPs, and
ardiologists extended to all evidence-based measures, pointing to gaps
n provider education (4).
Echocardiography for risk stratification based on HF risk profile or
creening for stage B HF is a different domain. In our paper, we have
xpressed concerns that screening—as the sole HF prevention strate-
y—is unlikely to have a tangible impact on HF burden, especially
hen limited to detection of left ventricular systolic dysfunction
LVSD). The limitations of LVSD screening are not remediable by
mproving patient selection or, alternatively, by containing the unit cost
f echocardiography; these limitations are rooted in the epidemiology
f HF. Most HF cases are older adults, most of whom have HF with
reserved ejection fraction, which carries mortality and population
ttributable risk of death (5) and cost of care (6) comparable to HF
ith reduced ejection fraction. Screening for LVSD, the primary use of
and-carried ultrasound, would not detect these cases. Therefore, the
ffectiveness of a screening strategy that misses most future cases, and
hat may result in false positives incurring expense and risk of
dditional testing, is dubious.
Screening may be beneficial for the individual patient with a high
re-test probability of potentially treatable findings—although this
ould have to include abnormalities beyond LVSD. From this
erspective, patient selection in combination with unit-cost con-
ainment is worth considering. In this spirit, hand-carried ultra-
ound is an interesting option for individuals with 10% projected
F risk, reserving the full test for those with positive/equivocal
ndings. Finally, the concordance in basic echocardiogram inter-
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Letters to the Editor 573pretation between experts and nonexperts has been observed in
relatively small studies; it remains to be determined whether this
applies in large-scale screening. In any case, we agree that, in this
era of increasing healthcare costs and complex economics, these
strategies would need evaluation in prospective studies.
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